SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-181336
Filing Date
2023-07-03
Accepted
2023-07-03 16:01:27
Documents
89
Period of Report
2023-06-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d490621d8k.htm   iXBRL 8-K 249515
2 EX-23.1 d490621dex231.htm EX-23.1 2155
3 EX-99.1 d490621dex991.htm   iXBRL EX-99.1 1183945
4 EX-99.2 d490621dex992.htm EX-99.2 125912
  Complete submission text file 0001193125-23-181336.txt   8879619

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA surf-20230630.xsd EX-101.SCH 63414
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20230630_cal.xml EX-101.CAL 69412
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20230630_def.xml EX-101.DEF 300613
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20230630_lab.xml EX-101.LAB 578103
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20230630_pre.xml EX-101.PRE 476289
83 EXTRACTED XBRL INSTANCE DOCUMENT d490621d8k_htm.xml XML 1661911
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38459 | Film No.: 231065265
SIC: 2836 Biological Products, (No Diagnostic Substances)